A citation-based method for searching scientific literature

Ajay Varanasi, Natalie Bellini, Deepti Rawal, Mehul Vora, Antoine Makdissi, Sandeep Dhindsa, Ajay Chaudhuri, Paresh Dandona. Eur J Endocrinol 2011
Times Cited: 97







List of shared articles



Times cited

Weight Management in Patients with Type 1 Diabetes and Obesity.
Adham Mottalib, Megan Kasetty, Jessica Y Mar, Taha Elseaidy, Sahar Ashrafzadeh, Osama Hamdy. Curr Diab Rep 2017
29

Current issues in GLP-1 receptor agonist therapy for type 2 diabetes.
Zachary T Bloomgarden, Lawrence Blonde, Alan J Garber, Carol H Wysham. Endocr Pract 2012
7


Adjuvant Liraglutide and Insulin Versus Insulin Monotherapy in the Closed-Loop System in Type 1 Diabetes: A Randomized Open-Labeled Crossover Design Trial.
Jeniece Trast Ilkowitz, Ranjitha Katikaneni, Martin Cantwell, Neesha Ramchandani, Rubina A Heptulla. J Diabetes Sci Technol 2016
12

Insulin therapy in type 2 diabetes mellitus.
Jack L Leahy. Endocrinol Metab Clin North Am 2012
19


Efficacy and safety of exenatide once weekly: an overview of the DURATION trials.
Christophe Em De Block, Luc F Van Gaal. Expert Rev Endocrinol Metab 2012
2

Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes.
Nitesh D Kuhadiya, Husam Ghanim, Aditya Mehta, Manisha Garg, Salman Khan, Jeanne Hejna, Barrett Torre, Antoine Makdissi, Ajay Chaudhuri, Manav Batra,[...]. J Clin Endocrinol Metab 2016
39

Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus.
Christian Seerup Frandsen, Thomas Fremming Dejgaard, Sten Madsbad. Lancet Diabetes Endocrinol 2016
46

Type 1 diabetes treatment beyond insulin: role of GLP-1 analogs.
Lindsay B Harrison, Pablo F Mora, Gregory O Clark, Ildiko Lingvay. J Investig Med 2013
35

The combination of insulin and GLP-1 analogues in the treatment of type 2 diabetes.
M M van der Klauw, B H R Wolffenbuttel. Neth J Med 2012
7


GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?
Djordje S Popovic, Edita Stokic, Stevan L Popovic. Curr Pharm Des 2015
4

Stabilization of postprandial blood glucose fluctuations by addition of glucagon like polypeptide-analog administration to intensive insulin therapy.
Susumu Ogawa, Kazuhiro Nako, Masashi Okamura, Takuya Sakamoto, Sadayoshi Ito. J Diabetes Investig 2015
8

Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitus.
Nitesh D Kuhadiya, Ritu Malik, Natalie J Bellini, Jane Lyons Patterson, Andrea Traina, Antoine Makdissi, Paresh Dandona. Endocr Pract 2013
55

Keeping the patient perspective: Where are we in the world of type 1 diabetes?
Jeremy Pettus, Matthias von Herrath. Clin Immunol 2013
0

Efficacy and safety of incretin-based drugs in patients with type 1 diabetes mellitus: A systematic review and meta-analysis.
Wen Wang, Yun Gao, Dawei Chen, Chun Wang, Xiaobing Feng, Xingwu Ran. Diabetes Res Clin Pract 2017
6

Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus.
Julia K Mader, Lene Jensen, Steen H Ingwersen, Erik Christiansen, Simon Heller, Thomas R Pieber. Clin Pharmacokinet 2016
6

Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production.
Lucy S Jun, Rohn L Millican, Eric D Hawkins, Debra L Konkol, Aaron D Showalter, Michael E Christe, M Dodson Michael, Kyle W Sloop. Diabetes 2015
36

Liraglutide for treating type 1 diabetes.
Thomas Fremming Dejgaard, Christian Seerup Frandsen, Jens Juul Holst, Sten Madsbad. Expert Opin Biol Ther 2016
9

Incretin-based therapy in combination with basal insulin: a promising tactic for the treatment of type 2 diabetes.
J Vora, S C Bain, T Damci, G Dzida, P Hollander, L F Meneghini, S A Ross. Diabetes Metab 2013
22

An update on the pharmacotherapy options for pediatric diabetes.
M Loredana Marcovecchio, Francesco Chiarelli. Expert Opin Biol Ther 2014
3

Once-weekly exenatide as adjunct treatment of type 1 diabetes mellitus in patients receiving continuous subcutaneous insulin infusion therapy.
Andrea N Traina, Melinda E Lull, Adrian C Hui, Toni M Zahorian, Jane Lyons-Patterson. Can J Diabetes 2014
33


GLP-1 Agonists in Type 1 Diabetes Mellitus.
Kristin M Janzen, Taylor D Steuber, Sarah A Nisly. Ann Pharmacother 2016
17

Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks.
Nitesh D Kuhadiya, Sandeep Dhindsa, Husam Ghanim, Aditya Mehta, Antoine Makdissi, Manav Batra, Sartaj Sandhu, Jeanne Hejna, Kelly Green, Natalie Bellini,[...]. Diabetes Care 2016
43


Nutrient induced type 2 and chemical induced type 1 experimental diabetes differently modulate gastric GLP-1 receptor expression.
Olga Bloch, Efrat Broide, Gilad Ben-Yehudah, Dror Cantrell, Haim Shirin, Micha J Rapoport. J Diabetes Res 2015
4


The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.
Kashif M Munir, Stephen N Davis. Expert Opin Pharmacother 2015
11

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.
Chantal Mathieu, Bernard Zinman, Joanna Uddén Hemmingsson, Vincent Woo, Peter Colman, Erik Christiansen, Martin Linder, Bruce Bode. Diabetes Care 2016
99

Synergy Between Gαz Deficiency and GLP-1 Analog Treatment in Preserving Functional β-Cell Mass in Experimental Diabetes.
Allison L Brill, Jaclyn A Wisinski, Mark T Cadena, Mary F Thompson, Rachel J Fenske, Harpreet K Brar, Michael D Schaid, Renee L Pasker, Michelle E Kimple. Mol Endocrinol 2016
13

ADJUNCT THERAPIES IN TYPE 1 DIABETES.
Paresh Dandona, Nitesh D Kuhadiya, Husam Ghanim, Ajay Chaudhuri. Endocr Pract 2016
2

Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia.
Thomas H Meek, Mauricio D Dorfman, Miles E Matsen, Jonathan D Fischer, Alexis Cubelo, Monica R Kumar, Gerald J Taborsky, Gregory J Morton. Diabetes 2015
21

Non-insulin pharmacological therapies for treating type 1 diabetes.
Christian Seerup Frandsen, Thomas Fremming Dejgaard, Sten Madsbad, Jens Juul Holst. Expert Opin Pharmacother 2018
5

Liraglutide as Adjunct to Insulin Treatment in Patients with Type 1 Diabetes: A Systematic Review and Meta-analysis.
Patoulias Dimitrios, Doumas Michael, Kotsis Vasilios, Stavropoulos Konstantinos, Imprialos Konstantinos, Zografou Ioanna, Petidis Konstantinos, Bakatselos Spyridon, Karagiannis Asterios. Curr Diabetes Rev 2020
12

Use of non-insulin therapies for type 1 diabetes.
Satish K Garg, Aaron W Michels, Viral N Shah. Diabetes Technol Ther 2013
8



Liraglutide acutely suppresses glucagon, lipolysis and ketogenesis in type 1 diabetes.
Manisha Garg, Husam Ghanim, Nitesh D Kuhadiya, Kelly Green, Jeanne Hejna, Sanaa Abuaysheh, Barrett Torre, Manav Batra, Antoine Makdissi, Ajay Chaudhuri,[...]. Diabetes Obes Metab 2017
14

Incretins: Beyond type 2 diabetes.
Paresh Dandona, Husam Ghanim, Ajay Chaudhuri. Diabetes Obes Metab 2018
5

Adjunctive therapy for glucose control in patients with type 1 diabetes.
Kira Harris, Cassie Boland, Lisa Meade, Dawn Battise. Diabetes Metab Syndr Obes 2018
9


The potential of incretin-based therapies in type 1 diabetes.
Chen S Suen, Paul Burn. Drug Discov Today 2012
19

Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
Thomas Fremming Dejgaard, Christian Seerup Frandsen, Tanja Stenbæk Hansen, Thomas Almdal, Søren Urhammer, Ulrik Pedersen-Bjergaard, Tonny Jensen, Andreas Kryger Jensen, Jens Juul Holst, Lise Tarnow,[...]. Lancet Diabetes Endocrinol 2016
71



Exenatide Increases IL-1RA Concentration and Induces Nrf-2‒Keap-1‒Regulated Antioxidant Enzymes: Relevance to β-Cell Function.
Paresh Dandona, Husam Ghanim, Sanaa Abuaysheh, Kelly Green, Sandeep Dhindsa, Antoine Makdissi, Manav Batra, Nitesh D Kuhadiya, Ajay Chaudhuri. J Clin Endocrinol Metab 2018
7